Channelopathies linked to plasma membrane phosphoinositides.
about
Voltage-Controlled Enzymes: The New JanusBifronsM1-muscarinic receptors promote fear memory consolidation via phospholipase C and the M-currentPhosphoinositides: tiny lipids with giant impact on cell regulationCoordinated signal integration at the M-type potassium channel upon muscarinic stimulationMembrane Protein Structure, Function, and Dynamics: a Perspective from Experiments and Theory.Regulation of KCNQ/Kv7 family voltage-gated K+ channels by lipids.Intracellular mechanisms of aminoglycoside-induced cytotoxicity.Inhibition of the TRPC5 ion channel protects the kidney filterThe phosphoinositide sensitivity of the K(v) channel family.Structural determinants of phosphatidylinositol 4,5-bisphosphate (PIP2) regulation of BK channel activity through the RCK1 Ca2+ coordination site.NHE3 activity is dependent on direct phosphoinositide binding at the N terminus of its intracellular cytosolic region.Ion channel associated diseases: overview of molecular mechanismsGating of a G protein-sensitive mammalian Kir3.1 prokaryotic Kir channel chimera in planar lipid bilayersInterplay Between Lipid Modulators of Kir2 Channels: Cholesterol and PIP2.A-kinase anchoring protein 150 mediates transient receptor potential family V type 1 sensitivity to phosphatidylinositol-4,5-bisphosphateA long QT mutation substitutes cholesterol for phosphatidylinositol-4,5-bisphosphate in KCNQ1 channel regulation.Phosphoinositides regulate ion channels.Voltage-sensing phosphatase modulation by a C2 domainTargeting the Small- and Intermediate-Conductance Ca-Activated Potassium Channels: The Drug-Binding Pocket at the Channel/Calmodulin InterfaceSelective phosphorylation modulates the PIP2 sensitivity of the CaM-SK channel complexGenetic defects in the hotspot of inwardly rectifying K(+) (Kir) channels and their metabolic consequences: a reviewPhosphatidylinositol-4,5-bisphosphate regulates epidermal growth factor receptor activationPhosphoinositide control of membrane protein function: a frontier led by studies on ion channels.The molecular mechanism by which PIP(2) opens the intracellular G-loop gate of a Kir3.1 channel.Pancreatic Beta Cell G-Protein Coupled Receptors and Second Messenger Interactions: A Systems Biology Computational AnalysisMolecular overlap in the regulation of SK channels by small molecules and phosphoinositidesOpposite Effects of the S4-S5 Linker and PIP(2) on Voltage-Gated Channel Function: KCNQ1/KCNE1 and Other Channels.Regulation of voltage-gated potassium channels by PI(4,5)P2PIP2 controls voltage-sensor movement and pore opening of Kv channels through the S4-S5 linker.Role of phosphoinositides at the neuronal synapse.Quantitative properties and receptor reserve of the IP(3) and calcium branch of G(q)-coupled receptor signaling.Phosphoinositides alter lipid bilayer properties.Phosphatidylinositol 4,5-bisphosphate alters pharmacological selectivity for epilepsy-causing KCNQ potassium channelsKv7.1 ion channels require a lipid to couple voltage sensing to pore opening.The Molecular Mechanism of Opening the Helix Bundle Crossing (HBC) Gate of a Kir Channel.Dynamic PIP2 interactions with voltage sensor elements contribute to KCNQ2 channel gatingThe ICl,swell inhibitor DCPIB blocks Kir channels that possess weak affinity for PIP2.Novel etiopathophysiological aspects of thyrotoxic periodic paralysis.Intrinsic control of sodium excretion in the distal nephron by inhibitory purinergic regulation of the epithelial Na(+) channel.Roles of ion transport in control of cell motility.
P2860
Q21129281-89341BA5-C130-44AD-A79C-7F3648B962A7Q24612782-B1F4AFFA-EC8C-4B94-830B-16D629F39405Q27012953-4678315D-CF59-4E05-9CAB-52AC326D0FD8Q28580624-AD0067E5-B344-40E7-BB08-FBAAA0B7F4C3Q30375519-BD72CA48-5BA7-4942-A4B1-472B3B1736C0Q30394930-42A3CC6E-626A-4AE1-AFF4-6DF61F9598C2Q30454411-0F6AED7F-EB36-44EB-9D11-486DA7ADD487Q30559274-F3E38F32-86F4-40AA-BE71-A8E9341BE9F6Q33702567-49A63CE9-D75E-4428-80E3-79498985A23EQ33846448-8AA73A09-1C5E-4F08-905A-488FB47BE8DEQ34251172-4A6E89AA-796B-4C34-AF13-80F165731947Q34311621-E7AA6BF1-6DD3-4696-9EDD-5BCB7D8FE086Q34400860-1BAA7FCB-A259-4E71-B43D-690BD41C7672Q34514622-FFE55813-06B6-4EA1-87BD-56EA766F573DQ35075369-369EF6C7-3102-4F62-A0E2-938B8AAE2B4CQ35134951-777D223A-94DE-43BD-8750-3FE423632978Q35192402-441ECBA1-B90F-49C4-89A3-F08881203B81Q35313400-479D1441-ADFF-4DF2-B74E-AFC635F8A8C2Q35329866-4645F485-E8A3-49BE-BDC0-CA107AFF3100Q35570980-B8E2511E-0A5A-4C73-9128-0B276575B658Q35661470-F01E3ECC-2F5E-4A13-AC98-8F03832D9EC4Q35762279-E3AB79EB-7A01-4C51-B26E-673FE37E2602Q35799988-078D7E56-2B51-4D76-99F6-EA8C09AED5B1Q35926194-D2414E34-746D-47D8-A604-322D31A2985AQ36006492-D483BE8A-550C-4AB4-986D-0B3BFC41F113Q36040703-9CE5BF64-7A31-4990-8FDE-3F3C48F80765Q36076020-7638FA4B-379A-40B9-9418-3F1AD9815924Q36130312-FD9EE648-9CBD-4BAB-AD9A-C44B7B31292EQ36221822-D6B45822-E9E4-4213-9F97-F0614D211A99Q36528090-36E8E634-634E-497A-B662-331131A9B760Q36804632-2B2CA04A-EB69-4764-BFF1-426E5679F448Q36878011-F870C311-3AFF-41D6-A8EF-67F1673FB4D9Q36884049-2DCE54F0-80B9-4008-BFAE-3EF3CBDE6837Q37088789-1B770181-9FA1-408C-85AC-AE777F43FF25Q37112835-39D6A06D-3FC1-4E04-A551-D47720B55AF7Q37395175-D0C1C39F-6FFE-4694-9E3B-FDDA6F709818Q37652401-2383A3DC-7B17-4CA1-AEBC-E1E3AAA8EFD6Q37873716-B55171C5-E8C2-45D9-906D-39B103E7B142Q37964952-7157CB0F-9C1A-4820-BC0E-EC8C5954CFDBQ38110508-49320E1B-3FFD-4653-AB8C-28E6D5AA1658
P2860
Channelopathies linked to plasma membrane phosphoinositides.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 16 April 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Channelopathies linked to plasma membrane phosphoinositides.
@en
Channelopathies linked to plasma membrane phosphoinositides.
@nl
type
label
Channelopathies linked to plasma membrane phosphoinositides.
@en
Channelopathies linked to plasma membrane phosphoinositides.
@nl
prefLabel
Channelopathies linked to plasma membrane phosphoinositides.
@en
Channelopathies linked to plasma membrane phosphoinositides.
@nl
P2860
P1433
P1476
Channelopathies linked to plasma membrane phosphoinositides
@en
P2093
Diomedes E Logothetis
Scott K Adney
P2860
P2888
P304
P356
10.1007/S00424-010-0828-Y
P577
2010-04-16T00:00:00Z